Influence of Medication on Functional Connectivity
Sponsor: National Institute on Drug Abuse (NIDA)
Listed as NCT03612713, this EARLY_PHASE1 trial focuses on Prescription Drug Abuse (Not Dependent) and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 14 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Jul 2022 — Apr 2024 [monthly]
Completed EARLY_PHASE1
Status: Recruiting → Completed
-
May 2022 — Jul 2022 [monthly]
Recruiting EARLY_PHASE1
▶ Show 9 earlier versions
-
Jan 2022 — May 2022 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2021 — Jan 2022 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
Status: Active Not Recruiting → Recruiting
-
May 2020 — Dec 2020 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2020 — May 2020 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2020 — Apr 2020 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2018 — Jan 2020 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Dec 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Sep 2018 — Oct 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Drug Abuse (NIDA)
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .